🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
MKC-NI-002 is a Phase 1b, randomized, double-blind, placebo-controlled stud...
Status
Completed
Location
VALDI
Start Date
2025-12-22
Trial ID
NCT07344558
Treatments Being Tested
To provide early access and to evaluate the safety and tolerability of nint...
Status
No Longer Available
Location
Centro Medico Santa Maria
Start Date
TBD
Trial ID
NCT02230982
Treatments Being Tested
This study is being done to evaluate the good and bad effects of BIBF1120 i...
Status
Withdrawn
Location
Cross Cancer Institute
Start Date
2014-07
Trial ID
NCT02152059
Treatments Being Tested
The aim of the study is to investigate the safety, tolerability, efficacy a...
Status
Completed
Location
1199.120.001 Boehringer Ingelheim Investigational Site
Start Date
2012-05
Trial ID
NCT01594125
The objective of this Phase III study is to evaluate the efficacy of ninted...
Status
Completed
Location
1199.52.0108 Boehringer Ingelheim Investigational Site
Start Date
2014-09-25
Trial ID
NCT02149108
Treatments Being Tested
To assess efficacy and safety of concomitant treatment with nintedanib and ...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2016-06-30
Trial ID
NCT02802345
Treatments Being Tested
Clinical study of HEC68498 in patients with advanced refractory solid tumor...
Status
Completed
Location
The Fifth Medical Center of PLA Ceneral Hospital
Start Date
2019-02-27
Trial ID
NCT04324372
Treatments Being Tested
Multi-center, non-interventional, prospective cohort study aiming to enroll...
Status
Completed
Location
University General Hospital of Evros
Start Date
2019-02-28
Trial ID
NCT03710824
Treatments Being Tested
The aim of this study was to evaluate the efficacy of two different doses o...
Status
Completed
Location
Multiple Locations
Start Date
2005-11
Trial ID
NCT02182063
Treatments Being Tested
To establish the bioequivalence of 1 soft gelatine capsule containing 200 m...
Status
Completed
Location
Boehringer Ingelheim Investigational Site
Start Date
2015-08
Trial ID
NCT02572752
Treatments Being Tested